Cargando…
Radiotherapy for meningiomas
Meningiomas are the most common primary central nervous system neoplasm. Despite promising recent progress in elucidating the genomic landscape and underlying biology of these histologically, molecularly, and clinically diverse tumors, the mainstays of meningioma treatment remain maximal safe resect...
Autores principales: | Chen, William C., Perlow, Haley K., Choudhury, Abrar, Nguyen, Minh P., Mirchia, Kanish, Youngblood, Mark W., Lucas, Calixto-Hope G., Palmer, Joshua D., Magill, Stephen T., Raleigh, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722800/ https://www.ncbi.nlm.nih.gov/pubmed/36315366 http://dx.doi.org/10.1007/s11060-022-04171-9 |
Ejemplares similares
-
Radiotherapy and radiosurgery for meningiomas
por: Chen, William C, et al.
Publicado: (2023) -
Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution
por: Lucas, Calixto-Hope, et al.
Publicado: (2023) -
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
por: Raleigh, David, et al.
Publicado: (2023) -
A case (report) for mechanistic validation of meningioma molecular therapies
por: Nguyen, Minh P, et al.
Publicado: (2022) -
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
por: Tang, Vivian, et al.
Publicado: (2023)